1. Academic Validation
  2. C24 Ceramide Lipid Nanoparticles for Skin Wound Healing

C24 Ceramide Lipid Nanoparticles for Skin Wound Healing

  • Pharmaceutics. 2025 Feb 12;17(2):242. doi: 10.3390/pharmaceutics17020242.
Ji-Hye Lee 1 Jin-Hyun Kim 1 Tong-Il Hyeon 1 Khee-Tae Min 1 Se-Young Lee 1 Han-Chul Ko 1 Hong-Seok Choi 1 Kuk-Youn Ju 1 Young-Seok Cho 2 Tae-Jong Yoon 1 3 4
Affiliations

Affiliations

  • 1 Moogene Medi Institute, 25, Misagangbyeonjungang-ro 7beonan-gil, Hanam 12939, Republic of Korea.
  • 2 Division of Gastroenterology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 505 Banpo-dong, Seoul 06591, Republic of Korea.
  • 3 Research Institute of Pharmaceutical Science and Technology (RIPST), College of Pharmacy, Ajou University, 206 Worldcup-ro, Yeongtong-gu, Suwon 16499, Republic of Korea.
  • 4 Department of BioHealth Regulatory Science, Graduate School of Ajou University, 206 Worldcup-ro, Yeongtong-gu, Suwon 16499, Republic of Korea.
Abstract

Background/Objectives: C24 ceramide plays a crucial role in skin regeneration and wound healing; however, its hydrophobic nature limits its application in therapeutic formulations. This study aims to enhance the bioavailability and efficacy of C24 ceramide by developing ceramide-based lipid nanoparticles (C24-LNP) and evaluate their impact on skin regeneration and wound healing. Methods: C24-LNP was synthesized and characterized for aqueous stability and bioavailability. In vitro experiments were conducted to assess its effects on keratinocyte proliferation and migration. Molecular biological analysis examined key signaling pathways, including Akt and ERK1/2 phosphorylation. Additionally, an in vivo mouse wound model was utilized to evaluate wound healing efficacy, with histological analysis performed to assess epidermal and dermal regeneration. Results: C24-LNP exhibited improved aqueous stability and bioavailability compared to free C24 ceramide. In vitro studies demonstrated that C24-LNP significantly promoted keratinocyte proliferation and migration. Molecular analysis revealed activation of the Akt and ERK1/2 signaling pathways, which are critical for cell growth and skin regeneration. In vivo wound healing experiments showed that C24-LNP accelerated wound closure compared to the control group. Histological analysis confirmed enhanced epidermal and dermal regeneration, leading to improved structural and functional skin repair. Conclusion: The lipid nanoparticle formulation of C24 ceramide effectively increases its bioavailability and enhances its therapeutic efficacy in skin regeneration and wound healing. C24-LNP presents a scalable and cost-effective alternative to traditional growth factor-based therapies, offering significant potential for clinical applications in wound care and dermatological treatments.

Keywords

C24 ceramide; collagen regeneration; lipid nanoparticle; re-epithelialization; wound healing.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-134508
    99.92%, PIP4K2C-mTOR Activator